8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)
Published . Updated .
Filed: 2026-10-08 AccNo: 0001501697-26-000081 Size: 175 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Directly affected
- XFOR X4 Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Filed: 2026-10-08 AccNo: 0001501697-26-000081 Size: 175 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligatio…
Source: sec-edgar
How far X4 Pharmaceuticals (XFOR) has moved since 8 Oct 2026
Since the first closing price after “8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer),” X4 Pharmaceuticals (XFOR) is -5.48%. The S&P 500 fund (SPY) is -1.53% over the same days, a -3.95% difference versus the market.
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +1.57% | final price |
| GLD | the next day | +0.93% | final price |
| GLD | two days later | +0.80% | final price |
| GLD | three days later | -0.70% | final price |
| GLD | three days earlier | +0.96% | final price |
| GLD | five days earlier | +0.41% | final price |
| QQQ | that day | +0.50% | final price |
| QQQ | the next day | -0.20% | final price |
| QQQ | two days later | -0.52% | final price |
| QQQ | three days later | -2.48% | final price |
| QQQ | three days earlier | +1.62% | final price |
| QQQ | five days earlier | +0.27% | final price |
| SPY | that day | +0.60% | final price |
| SPY | the next day | +0.54% | final price |
| SPY | two days later | +0.54% | final price |
| SPY | three days later | -0.55% | final price |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | -0.55% | final price |
| TLT | that day | +0.12% | final price |
| TLT | the next day | +0.21% | final price |
| TLT | two days later | +0.62% | final price |
| TLT | three days later | +1.30% | final price |
| TLT | three days earlier | -0.76% | final price |
| TLT | five days earlier | -0.49% | final price |
| X4 Pharmaceuticals (XFOR) | that day | +4.30% | final price |
| X4 Pharmaceuticals (XFOR) | the next day | +1.08% | final price |
| X4 Pharmaceuticals (XFOR) | two days later | -6.81% | final price |
| X4 Pharmaceuticals (XFOR) | three days later | -12.19% | final price |
| X4 Pharmaceuticals (XFOR) | three days earlier | -0.72% | final price |
| X4 Pharmaceuticals (XFOR) | five days earlier | +1.43% | final price |
Who gains and who loses around X4 Pharmaceuticals (XFOR)
Companies tied to this story
- XFOR X4 Pharmaceuticals
X4 Pharmaceuticals (XFOR) is linked, with no stored direction, high confidence in the 8 Oct 2026 story “8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> XFOR
- XPH State Street Spdr S&P Pharmaceuticals Etf
State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence in the 8 Oct 2026 story “8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer).” Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)” reaches X4 Pharmaceuticals (XFOR)
The 8 Oct 2026 story “8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)” names X4 Pharmaceuticals (XFOR) because of this story.
For X4 Pharmaceuticals (XFOR), the reason on file says SEC 8-K filing -> direct issuer disclosure -> XFOR
A second company, State Street Spdr S&P Pharmaceuticals Etf (XPH), is listed for a different reason: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for X4 Pharmaceuticals (XFOR)
XFOR traded between 2.43 and 3.71 across 10 sessions. The latest close on file is 2.76. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
What the saved facts support for X4 Pharmaceuticals (XFOR)
18 out of 100
“8-K - X4 Pharmaceuticals, Inc (0001501697) (Filer)” scores 18 out of 100. The score uses 1 sources, a +0.54% difference versus the S&P 500 (SPY), and 2 linked companies.